HighTower Advisors’s RxSight RXST Stock Holding History

HighTower Advisors’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-22,433	Closed	-$202K	–	3918
2025 Q3	$202K	Buy	+22,433	New	+$197K	﹤0.01%	3369
2025 Q1	–	Sell	-8,324	Closed	-$286K	–	4010
2024 Q4	$286K	Sell	8,324 -4,689	-36%	-$211K	﹤0.01%	2920
2024 Q3	$640K	Buy	13,013 +3,571	+38%	+$183K	﹤0.01%	2216
2024 Q2	$568K	Sell	9,442 -1,268	-12%	-$72.5K	﹤0.01%	2226
2024 Q1	$552K	Buy	10,710 +237	+2%	+$11.6K	﹤0.01%	2210
2023 Q4	$422K	Sell	10,473 -2,783	-21%	-$81.6K	﹤0.01%	2439
2023 Q3	$369K	Buy	13,256 +899	+7%	+$26.8K	﹤0.01%	2438
2023 Q2	$356K	Buy	12,357 +1,240	+11%	+$27.6K	﹤0.01%	2438
2023 Q1	$185K	Hold	11,117	–	–	﹤0.01%	2788
2022 Q4	$141K	Buy	11,117 +1,102	+11%	+$13.4K	﹤0.01%	2876
2022 Q3	$120K	Buy	+10,015	New	+$138K	﹤0.01%	2729
2021 Q4	–	Sell	-13,003	Closed	-$164K	–	3450
2021 Q3	$164K	Buy	+13,003	New	+$179K	﹤0.01%	2758

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

HighTower Advisors's RXST Position: Q4 2025 in Review

HighTower Advisors sold out of RxSight (RXST) in Q4 2025, closing a stake of 22,433 shares — an estimated $202K sold.

HighTower Advisors first reported a position in RXST in Q3 2021 and held it in 12 quarters. The position peaked at $640K in Q3 2024. 163 funds tracked by Wall St. Rank hold RXST as of Q4 2025.

HighTower Advisors reported no remaining RxSight position as of Q4 2025 after selling out during the quarter.
HighTower Advisors sold 22,433 RxSight shares in Q4 2025, an estimated $202K.
HighTower Advisors first reported a position in RxSight in Q3 2021 and held it in 12 quarters.
HighTower Advisors's RxSight position peaked at $640K in Q3 2024.
163 funds tracked by Wall St. Rank held RxSight as of Q4 2025.

Based on HighTower Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.